Safety and efficacy of peptide receptor radionuclide therapy in patients with advanced pheochromocytoma and paraganglioma: A single-institution experience and review of the literature.
Charlene Yu Lin TangWei Ming ChuaHian Liang HuangWinnie Wing-Chuen LamLih Ming LohDavid TaiSimon Yew Kuang OngSean Xuexian YanKelvin S H LokeDavid Chee-Eng NgWei Ying ThamPublished in: Journal of neuroendocrinology (2023)
This study suggests that PRRT is a safe and effective therapeutic option for patients with PPGL. Our findings align with the existing literature, providing additional evidence to support the use of PRRT in this challenging patient population.